Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Huanglian Jiedu Pills for excess heat/fire toxin syndrome
CTR20231136Phase 3Active
- Sponsor
- Institute of Chinese Materia Medica
- Start
- Sep 2023
- Countries
- 1
01
Overview
A Phase 3 trial of Huanglian Jiedu Decoction in acute pharyngitis, aphthosis (RAS), gingivitis, constipation, sponsored by Institute of Chinese Materia Medica. Started Sep 2023; status: active.
02
Drugs
Huanglian Jiedu Decoction
03
Conditions
acute pharyngitisaphthosis (RAS)gingivitisconstipation
Beyond the preview
Go deeper on CTR20231136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231136.